Dr. Diane Jennifer Prager, MD

Dr. Prager practices at Oncology Physicians Network of California in Victorville, California.

Dr. Prager's NPI, 1003883562, was assigned on March 3, 2006. Dr. Prager graduated from University of the Witwatersrand in 1982. Dr. Prager holds California license A49254.

Dr. Prager's primary practice is Oncology Physicians Network of California, at 12998 Hesperia Rd, Victorville, CA 92395 in San Bernardino County. The practice phone is (818) 507-4732.

Dr. Prager's primary practice is Oncology Physicians Network of California in Victorville, California. Dr. Prager is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Prager to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Prager practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Prager's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Prager is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Prager's licenses on file in 3 states: California, Washington and Illinois.

Dmand AI lists breast cancer, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Prager treats.

CMS data shows 14,745 Medicare services from Dr. Prager across 34 procedure codes in 2024, for 378 Medicare patients. Medicare paid $217,493 for them.

CMS counts 378 Medicare patients who saw Dr. Prager in 2024. The largest group is 65 to 74, with 159 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 15% are also on Medicaid. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Prager's median patient age at 57, with 76% women.

In 2024, Dr. Prager wrote 153 Medicare Part D claims for 41 patients. 80% of them were for generic drugs. CMS names the drug for 47 of them, across 2 drugs with 11 or more claims each, at $8,324 in total drug cost. In 2023, CMS named 178 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Prager for performance year 2024, reported as part of a group. Dr. Prager accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Prager as offering telehealth.

Dmand AI links 45 papers to Dr. Prager, published from 2005 to 2014. 2010 was the busiest year, with 2. The most frequent topics are Molecular Sequence Data, Insulin-Like Growth Factor I and Base Sequence. Dr. Prager has published most often in J Clin Oncol. Dr. Prager's most frequent co-authors are Shlomo Melmed, MD, Joseph D. Rosenblatt, MD and Chandra P. Belani, MD.

Dmand AI links Dr. Prager to 13 clinical trials, 5 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain. Jonsson Comprehensive Cancer Center sponsors the most, 2.

CMS Open Payments shows 203 general payments to Dr. Prager from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 81% of the total. Genentech, Inc. paid the most, $747.

Dmand AI lists 1 award for Dr. Prager, most recently CMS Stage 1 EHR in 2013.

Dr. Prager graduated from University of the Witwatersrand in 1982. Dr. Prager is a member of ACP.

Dr. Prager is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.